Hualan Biological Vaccine Future Growth
Future criteria checks 2/6
Hualan Biological Vaccine is forecast to grow earnings and revenue by 18.4% and 16.8% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
18.4%
Earnings growth rate
18.3%
EPS growth rate
| Biotechs earnings growth | 39.7% |
| Revenue growth rate | 16.8% |
| Future return on equity | 13.3% |
| Analyst coverage | Low |
| Last updated | 18 Sep 2024 |
Recent future growth updates
Recent updates
Potential Upside For Hualan Biological Vaccine Inc. (SZSE:301207) Not Without Risk
Jul 25
Hualan Biological Vaccine's (SZSE:301207) Upcoming Dividend Will Be Larger Than Last Year's
Jun 11Revenue Downgrade: Here's What Analysts Forecast For Hualan Biological Vaccine Inc. (SZSE:301207)
Apr 03Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next
Apr 02Hualan Biological Vaccine Inc.'s (SZSE:301207) Subdued P/E Might Signal An Opportunity
Apr 01An Intrinsic Calculation For Hualan Biological Vaccine Inc. (SZSE:301207) Suggests It's 31% Undervalued
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,502 | 1,236 | N/A | 982 | 2 |
| 12/31/2025 | 3,012 | 1,044 | N/A | 923 | 3 |
| 12/31/2024 | 2,553 | 876 | N/A | 1,134 | 3 |
| 6/30/2024 | 2,296 | 777 | 688 | 749 | N/A |
| 3/31/2024 | 2,300 | 805 | 724 | 792 | N/A |
| 12/31/2023 | 2,410 | 860 | 825 | 888 | N/A |
| 9/30/2023 | 1,984 | 645 | 752 | 813 | N/A |
| 6/30/2023 | 915 | 330 | 667 | 732 | N/A |
| 3/31/2023 | 1,956 | 614 | 459 | 533 | N/A |
| 1/1/2023 | 1,826 | 520 | 196 | 289 | N/A |
| 9/30/2022 | 1,997 | 598 | -162 | 233 | N/A |
| 6/30/2022 | 2,879 | 948 | -254 | 184 | N/A |
| 3/31/2022 | 1,833 | 624 | -216 | 274 | N/A |
| 1/1/2022 | 1,830 | 621 | -67 | 569 | N/A |
| 9/30/2021 | 2,608 | 1,004 | 124 | 608 | N/A |
| 6/30/2021 | 2,441 | 922 | 360 | 946 | N/A |
| 3/31/2021 | 2,439 | 934 | 285 | 897 | N/A |
| 12/31/2020 | 2,426 | 925 | 161 | 694 | N/A |
| 12/31/2019 | 1,049 | 375 | 131 | 275 | N/A |
| 12/31/2018 | 803 | 270 | 32 | 94 | N/A |
| 12/31/2017 | 285 | -77 | N/A | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301207's forecast earnings growth (18.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 301207's earnings (18.4% per year) are forecast to grow slower than the CN market (23% per year).
High Growth Earnings: 301207's earnings are forecast to grow, but not significantly.
Revenue vs Market: 301207's revenue (16.8% per year) is forecast to grow faster than the CN market (13.1% per year).
High Growth Revenue: 301207's revenue (16.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301207's Return on Equity is forecast to be low in 3 years time (13.3%).